Morgan Stanley’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.83M | Sell |
|
|||||
|
2025
Q1 | $11.1M | Sell |
|
|||||
|
2024
Q4 | $24.9M | Buy |
|
|||||
|
2024
Q3 | $5.84M | Sell |
|
|||||
|
2024
Q2 | $15.1M | Buy |
|
|||||
|
2024
Q1 | $23.5M | Sell |
|
|||||
|
2023
Q4 | $37.7M | Buy |
|
|||||
|
2023
Q3 | $17.8M | Buy |
|
|||||
|
2023
Q2 | $16.5M | Sell |
|
|||||
|
2023
Q1 | $15.6M | Sell |
|
|||||
|
2022
Q4 | $19.2M | Buy |
|
|||||
|
2022
Q3 | $13.3M | Sell |
|
|||||
|
2022
Q2 | $18.5M | Buy |
|
|||||
|
2022
Q1 | $18.7M | Buy |
|
|||||
|
2021
Q4 | $12.3M | Sell |
|
|||||
|
2021
Q3 | $14.8M | Sell |
|
|||||
|
2021
Q2 | $32.8M | Buy |
|
|||||
|
2021
Q1 | $18.5M | Buy |
|
|||||
|
2020
Q4 | $13.8M | Sell |
|
|||||
|
2020
Q3 | $16.2M | Buy |
|
|||||
|
2020
Q2 | $6.34M | Sell |
|
|||||
|
2020
Q1 | $28.5M | Buy |
|
|||||
|
2019
Q4 | $6.08M | Buy |
|
|||||
|
2019
Q3 | $8.89M | Sell |
|
|||||
|
2019
Q2 | $17.4M | Buy |
|
|||||
|
2019
Q1 | $13M | Sell |
|
|||||
|
2018
Q4 | $8.29M | Sell |
|
|||||
|
2018
Q3 | $13.4M | Sell |
|
|||||
|
2018
Q2 | $18.9M | Sell |
|
|||||
|
2018
Q1 | $25.6M | Sell |
|
|||||
|
2017
Q4 | $31.8M | Buy |
|
|||||
|
2017
Q3 | $3.59M | Buy |
|
|||||
|
2017
Q2 | $4.01M | Buy |
|
|||||
|
2017
Q1 | $3.51M | Sell |
|
|||||
|
2016
Q4 | $4.98M | Buy |
|
|||||
|
2016
Q3 | $993K | Sell |
|
|||||
|
2016
Q2 | $2.16M | Buy |
|
|||||
|
2016
Q1 | $304K | Buy |
|
|||||
|
2015
Q4 | $440K | Sell |
|
|||||
|
2015
Q3 | $357K | Sell |
|
|||||
|
2015
Q2 | $1.37M | Buy |
|
|||||
|
2015
Q1 | $331K | Buy |
|
|||||
|
2014
Q4 | $72K | Buy |
|
|||||
|
2014
Q3 | $58K | Buy |
|